Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
LumiraDx Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.02 |
52 Week High | US$0.55 |
52 Week Low | US$0.007 |
Beta | 0.27 |
1 Month Change | -20.00% |
3 Month Change | 119.78% |
1 Year Change | -95.24% |
3 Year Change | -99.80% |
5 Year Change | n/a |
Change since IPO | n/a |
Recent News & Updates
Recent updates
Market Cool On LumiraDx Limited's (NASDAQ:LMDX) Revenues Pushing Shares 27% Lower
Dec 20LumiraDx Limited's (NASDAQ:LMDX) Revenues Are Not Doing Enough For Some Investors
Apr 17What You Need To Know About The LumiraDx Limited (NASDAQ:LMDX) Analyst Downgrade Today
Nov 16Need To Know: The Consensus Just Cut Its LumiraDx Limited (NASDAQ:LMDX) Estimates For 2022
Aug 20LumiraDx GAAP EPS of -$0.58, revenue of $44.7M
Aug 18Bill & Melinda Gates Foundation discloses 7.4% passive stake in LumiraDx
Jul 15Shareholder Returns
LMDX.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | -8.7% | -0.8% | -0.6% |
1Y | -95.2% | 1.9% | 22.5% |
Return vs Industry: LMDX.F underperformed the US Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: LMDX.F underperformed the US Market which returned 22.5% over the past year.
Price Volatility
LMDX.F volatility | |
---|---|
LMDX.F Average Weekly Movement | 33.1% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: LMDX.F's share price has been volatile over the past 3 months.
Volatility Over Time: LMDX.F's weekly volatility has decreased from 41% to 33% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 1,210 | Veronique Ameye | www.lumiradx.com |
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care.
LumiraDx Limited Fundamentals Summary
LMDX.F fundamental statistics | |
---|---|
Market cap | US$7.18m |
Earnings (TTM) | -US$338.03m |
Revenue (TTM) | US$126.52m |
0.1x
P/S Ratio0.0x
P/E RatioIs LMDX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LMDX.F income statement (TTM) | |
---|---|
Revenue | US$126.52m |
Cost of Revenue | US$131.23m |
Gross Profit | -US$4.71m |
Other Expenses | US$333.32m |
Earnings | -US$338.03m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.94 |
Gross Margin | -3.73% |
Net Profit Margin | -267.19% |
Debt/Equity Ratio | -201.0% |
How did LMDX.F perform over the long term?
See historical performance and comparison